No insider purchase over the last 90 days. The latest, by ZORETIC RICHARD C, was filed 30 May 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
25 of 119 declarations
On September 24, 2026, Ignite Aggregator LP, filed as 10% Owner, sold EUR 81,270,497 at InnovAge Holding Corp., nearly all of the record's 16 sales (EUR 81.8 million, median EUR 23,373). Nicole Damato, CHIEF LEGAL OFFICER, sold EUR 182,051 on September 25, 2026, and Michael Anthony Scarbrough (President and COO) EUR 139,013 on November 14, 2025.
The 16 purchases total EUR 1.5 million (median EUR 37,582), or 50% of open-market trades. Thomas Scully (Director) bought EUR 510,396 on September 15, 2022; Edward Moore Kennedy Jr. (Director) EUR 405,010 on March 8, 2021 and Maureen Hewitt (CEO, President and Director) EUR 207,655 on March 12, 2021. From March 8, 2021 to March 15, 2021, 4 filers bought EUR 697,153. Across the full history, 11 purchase filings are classed as clustered. Richard C. Zoretic, Director, signs 8 purchases in 10 filings.
115 filings from March 8, 2021 to September 29, 2026, 76 of them grants: 5 in 2021, 8 in 2022, then 23, 30 and 31 from 2023 to 2025. Nicole Damato signs 32 filings, 13 of them sales, Patrick T. Blair (CHIEF EXECUTIVE OFFICER) 24 with no open-market trade. The US healthcare and pharma company is worth USD 1.21 billion, with 61.3% held by insiders. Last twelve months: 20 filings, 4 sales, no purchase. For the 16 purchases with a result, the 90-day median is -11.7%, with 6% of results positive (recorded past, not a forecast).
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Jun 2026 | 989.7 m USD | -2.5 m USD | -0.02 USD | 10-K |
| Jun 2025 | 853.7 m USD | -30.3 m USD | -0.22 USD | 10-K |
| Jun 2024 | 763.9 m USD | -21.3 m USD | -0.16 USD | 10-K |
| Jun 2023 | 688.1 m USD | -40.7 m USD | -0.30 USD | 10-K |
| Jun 2022 | 698.6 m USD | -6.5 m USD | -0.05 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.